Several lymphoma-specific genetic events in parallel can be found in mature B-cell neoplasms

Genes Chromosomes and Cancer

Volumn 50, Issue 1, 2011, Pages 43-50

  Bacher, Ulrike ^a   Haferlach, Torsten ^b   Alpermann, Tamara ^b   Kern, Wolfgang ^b   Schnittger, Susanne ^b   Haferlach, Claudia ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b MLL MUNICH LEUKEMIA LABORATORY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CHROMOSOME BANDING PATTERN; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; FOLLOW UP; GENE DELETION; HOMOZYGOSITY; HUMAN; INTERPHASE; KARYOTYPE; LARGE CELL LYMPHOMA; LYMPHOMA; MALE; PRIORITY JOURNAL; REMISSION;

AGED; AGED, 80 AND OVER; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 18; COHORT STUDIES; DATABASES, GENETIC; FEMALE; GENE DELETION; GENE REARRANGEMENT; GENES, IMMUNOGLOBULIN HEAVY CHAIN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, B-CELL; MALE; MIDDLE AGED; TRANSLOCATION, GENETIC;

EID: 78249274234     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20831     Document Type: Article

References (22)

1. Aamot HV, Torlakovic EE, Eide MB, Holte H, Heim S. 2007. Non-Hodgkin lymphoma with t(14;18): Clonal evolution patterns and cytogenetic-pathologic-clinical correlations. J Cancer Res Clin Oncol 133: 455-470.
2. Au WY, Gascoyne RD, Viswanatha DS, Skinnider BF, Connors JM, Klasa RJ, Horsman DE. 1999. Concurrent chromosomal alterations at 3q27, 8q24 and 18q21 in B-cell lymphomas. Br J Haematol 105: 437-440.
3. Chigrinova E, Mian M, Scandurra M, Greiner TC, Chan WC, Vose JM, Inghirami G, Chiappella A, Baldini L, Ponzoni M, Ferreri AJ, Franceschetti S, Gaidano G, Tucci A, Facchetti F, Lazure T, Lambotte O, Montes-Moreno S, Piris MA, Nomdedeu JF, Uccella S, Rancoita PM, Kwee I, Zucca E, Bertoni F. Diffuse large B-cell lymphoma with concordant bone marrow involvement has peculiar genomic profile and poor clinical outcome. Hematol Oncol 2010 Jul 15 (epub ahead of print).
4. Copie-Bergman C, Gaulard P, Leroy K, Briere J, Baia M, Jais JP, Salles GA, Berger F, Haioun C, Tilly H, Emile JF, Banham AH, Mounier N, Gisselbrecht C, Feugier P, Coiffier B, Molina TJ. 2009. Immuno-fluorescence in situ hybridization index predicts survival in patients with diffuse large B-cell lymphoma treated with R-CHOP: A GELA study. J Clin Oncol 27: 5573-5579.
5. D'Achille P, Seymour JF, Campbell LJ. 2006. Translocation (14;18)(q32;q21) in acute lymphoblastic leukemia: A study of 12 cases and review of the literature. Cancer Genet Cytogenet 171: 52-56.
6. Dave SS, Fu K, Wright GW, Lam LT, Kluin P, Boerma EJ, Greiner TC, Weisenburger DD, Rosenwald A, Ott G, Muller-Hermelink HK, Gascoyne RD, Delabie J, Rimsza LM, Braziel RM, Grogan TM, Campo E, Jaffe ES, Dave BJ, Sanger W, Bast M, Vose JM, Armitage JO, Connors JM, Smeland EB, Kvaloy S, Holte H, Fisher RI, Miller TP, Montserrat E, Wilson WH, Bahl M, Zhao H, Yang L, Powell J, Simon R, Chan WC, Staudt LM. 2006. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med 354: 2431-2442.
7. Dicker F, Schnittger S, Haferlach T, Kern W, Schoch C. 2006. Immunostimulatory oligonucleotide-induced metaphase cytogenetics detect chromosomal aberrations in 80% of CLL patients: A study of 132 CLL cases with correlation to FISH, IgVH status, and CD38 expression. Blood 108: 3152-3160.
8. Gilliland DG. 2001. Hematologic malignancies. Curr Opin Hematol 8: 189-191.
9. Haferlach C, Dicker F, Schnittger S, Kern W, Haferlach T. 2007. Comprehensive genetic characterization of CLL: A study on 506 cases analysed with chromosome banding analysis, interphase FISH, IgV(H) status and immunophenotyping. Leukemia 21: 2442-2451.
10. Henderson LJ, Okamoto I, Lestou VS, Ludkovski O, Robichaud M, Chhanabhai M, Gascoyne RD, Klasa RJ, Connors JM, Marra MA, Horsman DE, Lam WL. 2004. Delineation of a minimal region of deletion at 6q16.3 in follicular lymphoma and construction of a bacterial artificial chromosome contig spanning a 6-megabase region of 6q16-q21. Genes Chromosomes Cancer 40: 60-65.
11. Jardin F, Jais JP, Molina TJ, Parmentier F, Picquenot JM, Ruminy P, Tilly H, Bastard C, Salles G. Press Feugier P, Thieblemont C, Gisselbrecht C, de RA, Coiffier B, Haioun C, Leroy K. 2010. Diffuse large B-cell lymphomas with CDKN2A deletion have a distinct gene expression signature and a poor prognosis under R-CHOP treatment: A GELA study. Blood 116: 1092-1104.
12. Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, Dyer MJ, Siebert R, Kuruvilla J, Klasa R, Connors JM, Gascoyne RD, Horsman DE. 2009. Lymphomas with concurrent BCL2 and MYC translocations: The critical factors associated with survival. Blood 114: 2273-2279.
13. Kern W, Dicker F, Schnittger S, Haferlach C, Haferlach T. 2009. Correlation of flow cytometrically determined expression of ZAP-70 using the SBZAP antibody with IgVH mutation status and cytogenetics in 1, 229 patients with chronic lymphocytic leukemia. Cytometry B Clin Cytom 76: 385-393.
14. Le Gouill S, Talmant P, Touzeau C, Moreau A, Garand R, Juge-Morineau N, Gaillard F, Gastinne T, Milpied N, Moreau P, Harousseau JL, Avet-Loiseau H. 2007. The clinical presentation and prognosis of diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC rearrangement. Haematologica 92: 1335-1342.
15. Mitelman F, Johansson B, Mertens F. 2009. Mitelman Database of Chromosome Aberrations in Cancer. Available at: Last accessed October 2009.
16. Niitsu N, Okamoto M, Miura I, Hirano M. 2009. Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia 23: 777-783.
17. Reilly JT. 2005. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): A paradigm for understanding leukaemogenesis? Br J Haematol 128: 18-34.
18. Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal CP, Ferry JA, Harris NL, Hasserjian RP, Zukerberg LR, Abramson JS, Hochberg EP, Lee H, Lee AI, Toomey CE, Sohani AR. 2010. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol 34: 327-340.
19. Stamatoullas A, Buchonnet G, Lepretre S, Lenain P, Lenormand B, Duval C, Callat MP, Gaulard P, Bastard C, Tilly H. 2000. De novo acute B cell leukemia/lymphoma with t(14;18). Leukemia 14: 1960-1966.
20. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, and Vardiman JW. 2008. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press.
21. Tomita N, Tokunaka M, Nakamura N, Takeuchi K, Koike J, Motomura S, Miyamoto K, Kikuchi A, Hyo R, Yakushijin Y, Masaki Y, Fujii S, Hayashi T, Ishigatsubo Y, Miura I. 2009. Clinicopathological features of lymphoma/leukemia patients carrying both BCL2 and MYC translocations. Haematologica 94: 935-943.
22. Wang HY, Bossler AD, Schaffer A, Tomczak E, DiPatri D, Frank DM, Nowell PC, Bagg A. 2007. A novel t(3;8)(q27;q24.1) simultaneously involving both the BCL6 and MYC genes in a diffuse large B-cell lymphoma. Cancer Genet Cytogenet 172: 45-53.